USA Pharmaceutical Pricing & Reimbursement Concise Guide 2016 – Research and Markets

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: USA" report to their offering.

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered:

1. HEALTHCARE SYSTEM

• Provision & Funding
• Patient Protection and Affordable Care Act
• Medicare
• Medicaid
• Uninsured

2. PRICING

• Prescription Drugs
• Price Controversies
• Pricing Benchmarks
• Private Payers
• Medicare
• Medicaid
• Generic Drugs
• Private Payers
• Medicare
• Medicaid
• Hospital Drugs
• Procurement
• 340B Drug Programme
• OTC Drugs

3. REIMBURSEMENT

• Admission to Reimbursement
• Private Payers
• Medicare
• Medicaid
• Other Federal Programmes
• Reimbursement Categories
• Private Payers
• Reimbursement Prices
• Hospital Reimbursement
• 340B Programme
• Changes in Reimbursement Status
• Changes in Reimbursement Prices

4. PHARMACOECONOMICS

• Pharmacoeconomic Requirements
• Private Payers
• Medicare
• Medicaid
• Patient-Centered Outcomes Research Institute

5. PRICE BUILD UP

• Wholesalers
• Margins
• Background
• Retail Pharmacies
• Margins
• Dispensing Fees
• Background
• Dispensing Doctors
• Sales Tax
• Prescription Drugs
• OTC Drugs

6. COST CONTAINMENT

• Industry Paybacks
• Annual Fees
• User Fees
• Promotional Costs
• Advertising
• Payments to Physicians
• Patient Co-payments
• Private Payers
• Medicare
• Medicaid
• Pharmaceutical Assistance Programmes
• Uninsured
• Prescribing Controls
• Formularies
• Utilisation Controls
• Off-label Prescribing
• Monitoring
• Other Initiatives
• Generics

7. FUTURE DEVELOPMENTS

• Healthcare Reform
• Drug Pricing Proposals
• Medicare Part D Price Negotiations
• Medicare Part B Reimbursement Reform
• Medicaid Rebate
• State-level Action on Drug Pricing
• MAC Transparency

8. NAMES & ADDRESSES

For more information about this report visit http://www.researchandmarkets.com/research/kf5qvr/ims

View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006124/en/

Research and Markets

Laura Wood, Senior Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Topics: Pharmaceuticals, Pharmacoeconomics

Source: Research and Markets